As per technical charts, ORCHID CHEMICAL and PHARMACEUTICALS can be purchased at current market price with stop loss of Rs 260 for the target of Rs 268-274. This is a day trading recommendation.

The stock of the company is currently trading at a P/E of 11 and offers an earning per share of Rs 23.13.

ORCHID CHEMICAL and PHARMACEUTICALS is a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well as in drug discovery.

The company has long-term exclusive marketing alliances with reputed global companies such as Apotex, Actavis, Dava and Hospira for distribution of Orchid’s products in the advanced markets in the US and Europe.

On National Stock Exchange, the stock has touched a 52-week high of Rs 284 and a low of Rs 174.

Other stocks from the pharmaceutical sector are also looking good at current prices which includes Sun Pharma, Cipla, Ranbaxy Labs and Glenmark.